THC Tenet Healthcare Corp

  1. Stocks
  2. Healthcare
  3. NYSE: THC

Price (delayed)

$280.77

Market cap

$22.61B

P/E Ratio

10.75

Dividend/share

N/A

EPS

$26.11

Enterprise value

$33.69B

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 87
Relative Valuation: Rel. Valuation: 94
Relative Profitability: Rel. Profitability: 98

Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ...

Highlights
The EPS has surged by 65% year-on-year and by 35% since the previous quarter
The net income has soared by 51% YoY and by 32% from the previous quarter
The equity has grown by 24% YoY but it has contracted by 3.2% from the previous quarter
Tenet Healthcare's quick ratio has decreased by 29% YoY and by 5% QoQ
The P/E is 10% more than the 5-year quarterly average of 9.8
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.tenethealth.com
Peers: CYH UHS HCA MD

Key stats

What are the main financial stats of THC

THC stock price

How has the Tenet Healthcare stock price performed over time
Intraday
3%
1 week
4.8%
1 month
42.89%
1 year
58.28%
YTD
41.29%
QTD
50.08%

Financial performance

How have Tenet Healthcare's revenue and profit performed over time
Revenue
$22.64B
Gross profit
$22.64B
Operating income
$4.28B
Net income
$2.24B
Gross margin
100%
Net margin
9.9%
The net income has soared by 51% YoY and by 32% from the previous quarter
THC's net margin is up by 38% YoY and by 27% from the previous quarter
THC's operating income is up by 25% year-on-year and by 19% since the previous quarter
The operating margin rose by 15% since the previous quarter and by 15% year-on-year

Price vs fundamentals

How does THC's price correlate with its fundamentals

Growth

What is Tenet Healthcare's growth rate over time

Valuation

What is Tenet Healthcare stock price valuation
THC P/E details
P/E
10.75
P/B
5.19
P/S
1.04
EV/EBIT
8.98
EV/EBITDA
7.25
EV/Sales
1.49
The EPS has surged by 65% year-on-year and by 35% since the previous quarter
The P/E is 10% more than the 5-year quarterly average of 9.8
THC's price to book (P/B) is 33% higher than its last 4 quarters average of 3.9 and 6% higher than its 5-year quarterly average of 4.9
The equity has grown by 24% YoY but it has contracted by 3.2% from the previous quarter
The stock's price to sales (P/S) is 108% more than its 5-year quarterly average of 0.5 and 30% more than its last 4 quarters average of 0.8
Tenet Healthcare's revenue has increased by 9% YoY and by 3.5% from the previous quarter

Efficiency

How efficient is Tenet Healthcare business performance
Tenet Healthcare's return on assets has increased by 45% YoY and by 30% QoQ
The ROE has grown by 36% YoY and by 25% from the previous quarter
THC's ROIC is up by 26% year-on-year and by 22% since the previous quarter
The return on sales has increased by 19% since the previous quarter and by 19% year-on-year

Dividends

What is THC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for THC.

Financial health

How did Tenet Healthcare financials performed over time
The total assets is 40% more than the total liabilities
Tenet Healthcare's quick ratio has decreased by 29% YoY and by 5% QoQ
The current ratio fell by 18% YoY but it rose by 3.7% QoQ
THC's debt is 184% more than its equity
The equity has grown by 24% YoY but it has contracted by 3.2% from the previous quarter
The debt to equity has contracted by 19% YoY but it has grown by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.